SCHEDULE 13D/A: Skycrest Holdings Amends Zeo Scientifix Stake, Increases Common Stock Holdings Amidst Share Dilution

Skycrest Holdings, LLC has filed an Amendment No. 2 to its Schedule 13D, reporting an updated beneficial ownership of 4.59% in Zeo Scientifix, Inc. common stock, reflecting recent open market purchases and gifts of other securities.

Summary

• Skycrest Holdings, LLC filed Amendment No. 2 to its Schedule 13D regarding its stake in Zeo Scientifix, Inc.
• The reporting person now beneficially owns 302,167 shares of Zeo Scientifix common stock.
• This represents 4.59% of the common stock class, based on 6,582,419 shares outstanding as of September 13, 2024.
• The additional common stock shares were acquired through open market purchases funded by the Reporting Person's working capital.
• Recent transactions include purchases of common stock between November 18, 2024, and December 11, 2024, and gifts of Warrants to Purchase Common Stock and Series C Preferred Stock in December 2024.
• The Reporting Person ceased to be the beneficial owner of 50 shares of Series C Preferred Stock on December 30, 2024.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive due to the continued open market purchases of common stock by Skycrest Holdings, indicating ongoing confidence in Zeo Scientifix. However, this is somewhat tempered by the gifting of a significant number of warrants and preferred stock, and the overall percentage ownership decrease, which could be interpreted as a partial divestment or rebalancing of their stake.

Positives

• Skycrest Holdings, LLC continued to acquire common stock of Zeo Scientifix, Inc. through open market purchases, indicating continued investment interest.
• The purchases were funded by the Reporting Person's working capital, suggesting internal financial strength for these investments.

Negatives

• The Reporting Person gifted 750,000 Warrants to Purchase Common Stock on December 20, 2024, and an additional 350,000 Warrants on December 26, 2024.
• The Reporting Person gifted 50 shares of Series C Preferred Stock on December 30, 2024, ceasing beneficial ownership of these shares.
• Despite recent common stock purchases, Skycrest Holdings, LLC's beneficial ownership percentage decreased to 4.59% (from a previously implied higher percentage, given the increase in outstanding shares), which could be viewed as a relative reduction in stake.

Risks

• The Reporting Person has no definite plan to acquire or dispose of additional shares, which could lead to uncertainty regarding their future involvement or potential divestment.
• The gifting of a significant number of warrants and preferred stock by the Reporting Person could indicate a reduction in their overall exposure or a shift in their investment strategy, potentially impacting market perception.

Future Outlook

Skycrest Holdings, LLC has no definite plan to acquire or dispose of additional shares of Zeo Scientifix, Inc. common stock in open market or private transactions, but may do so in the future, subject to compliance with the Exchange Act and its regulations.

Industry Context

NA

Stakeholder Impact

• Shareholders: The change in beneficial ownership and the nature of transactions (purchases vs. gifts) could influence investor perception and potentially the stock price.

Next Steps

• Skycrest Holdings, LLC may acquire or dispose of additional shares of Zeo Scientifix, Inc. common stock in the future, subject to regulatory compliance.

Key Dates

Recommendation

Keywords

Zeo Scientifix, Skycrest Holdings, Schedule 13D, beneficial ownership, common stock, preferred stock, warrants, SEC filing, investor update, equity stake